James C. Eisenach MD

Dr. Eisenach, the overall director of the laboratory, has a long history of scientific review and administration and of NIH funded research. He is the recipient of over $12 million in R01 support and $2 million in industry support since coming to Wake Forest University School of Medicine in 1985, and is currently PI on two RO1 grants and Co-PI on two other R01 grants. He was the PI for the pivotal multi-center trial leading to FDA approval of epidural clonidine for intractable neuropathic pain associated with cancer.

Dr. Eisenach holds 4 INDs from the FDA for novel analgesic drugs and one patent for a novel treatment for pain in women. He is a past member and chairman of the Anesthetic and Life Support Drugs Advisory Committee at the FDA. In addition to serving on several review committees for the NIH, VA, and national anesthesiology societies, he has been the Vice-Chairman for Research in the Department of Anesthesiology since 1998. Dr. Eisenach has trained 30 post-doctoral and undergraduate fellows and students since 1985. He has organized two major pain symposia at IASP international meetings. He is the current Editor-in-Chief of Anesthesiology.